System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Editorial Ppublish 1 citation

PubMed: 36389334 DOI: 10.21037/jtd-22-1128

The quality of systematic reviews on the treatment of stage I non-small cell lung cancer for individualized decision-making: improved but further refinements are needed.

J Thorac Dis 14(10):3660-3666

Authors: Yajia Sun, Qianling Shi, Anya Shi, Yaolong Chen

Affiliations

  • School of Public Health, Lanzhou University, Lanzhou, China.
  • The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
  • The Second Clinical Medical Hospital, Lanzhou University, Lanzhou, China.
  • School of Public Health, Lanzhou University, Lanzhou, China. Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences (2021RU017), School of Basic Medical Sciences, Lanzhou University, Lanzhou, China. Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China. Lanzhou University Institute of Health Data Science, Lanzhou, China.

MeSH

Decision Making, Carcinoma, Non-Small-Cell Lung, Cells, Therapeutics, Lung Neoplasms, Small Cell Lung Carcinoma